Baebies Overview
- Status
-
Private
- Employees
-
121
- Latest Deal Type
-
Grant
- Latest Deal Amount
-
$266K
- Investors
-
36
Baebies General Information
Description
Developer of screening and pediatric testing technology intended to save the lives of newborns. The company's technology operates on digital microfluidics which maximizes diagnostic yield from low-volume samples, one drop of blood is used to quantitatively measure the activity of lysosomal enzymes from newborn dried blood spot specimens, enabling physicians with early disease detection and multifunctional diagnostic testing for children and adults.
Contact Information
Website
www.baebies.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Primary Office
- 25 Alexandria Way
- Durham, NC 27703
- United States
+1 (919) 000-0000
Baebies Timeline
Baebies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 22. Grant | 23-May-2022 | $266K | 000.00 | Completed | Generating Revenue | |
| 21. Later Stage VC | 03-May-2022 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 20. Grant | 21-Sep-2021 | 00000 | 000.00 | Completed | Generating Revenue | |
| 19. Later Stage VC (Series B) | 25-May-2021 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 18. Grant | 19-May-2021 | 00.00 | 00.00 | Completed | Generating Revenue | |
| 17. Grant | 20-Apr-2021 | 000.00 | 00.00 | Completed | Generating Revenue | |
| 16. Grant | 11-Feb-2021 | 000 | 00.00 | Completed | Generating Revenue | |
| 15. Grant | 18-Jun-2020 | 000 | 00.00 | Completed | Generating Revenue | |
| 14. Debt - PPP | 15-Apr-2020 | $1.61M | $9.4M | Completed | Generating Revenue | |
| 13. Grant | 01-Mar-2020 | $171K | $9.4M | Completed | Generating Revenue |
Baebies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | 00,000,000 | 00.000000 | 00 | 00 | 00 | 00 | 000 | |
| Series A1 | 0,000,000 | 00.000000 | 00.0 | 00.0 | 00 | 00.0 | 0.000 | |
| Series A | 16,250,000 | $0.000100 | $0.8 | $0.8 | 1x | $0.8 | 32.5% |
Baebies Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Financing
Details
Developer of screening and pediatric testing technology intended to save the lives of newborns. The company's technology
Diagnostic Equipment
Durham, NC
121
As of 2022
000.00
0000000000
000.00
000000
ididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud
0000000000 000000000
Brea, CA
00000
As of 0000
0.000
0000-00-00
000000&0
000000
voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occa
0000000000 000000000
Waltham, MA
00000
As of 0000
00000000
Add Comparison
Baebies Competitors (10)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Beckman Coulter | Corporate Backed or Acquired | Brea, CA | 00000 | 000000&0 | ||
| 00000000000 | Corporation | Waltham, MA | 00000 | 00000000 | ||
| 000000000000 | Private Equity-Backed | Puteaux, France | 000 | 000.00 | 000000000000 | |
| 000000 000000000 | Formerly VC-backed | Abingdon, United Kingdom | 000 | 00000 | 000000&0 | 00000 |
| 000000000 | Venture Capital-Backed | Newcastle Upon Tyne, United Kingdom | 000 | 00000 | 0000000000 0 | 00000 |
Baebies Patents
Baebies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220220530-A1 | Detection of glycosaminoglycans | Pending | 23-May-2019 | 00000000 | |
| US-11035855-B2 | Point-of-birth system and instrument, biochemical cartridge, and methods for newborn screening | Active | 29-Apr-2016 | 000000000000 | |
| US-20210311042-A1 | Point-of-birth system and instrument, biochemical cartridge, and methods for newborn screening | Pending | 29-Apr-2016 | 000000000000 | |
| AU-2017257183-A1 | Point-of-birth system and instrument, biochemical cartridge, and methods for newborn screening | Active | 29-Apr-2016 | 000000000000 | |
| CA-3021348-A1 | Point-of-birth system and instrument, biochemical cartridge, and methods for newborn screening | Pending | 29-Apr-2016 | G01N33/54366 |
Baebies Executive Team (8)
Baebies Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Dennis Sacha | Self | Board Member | 000 0000 |
| Nicholas Naclerio Ph.D | Illumina Ventures | Board Member | 000 0000 |
| Richard West Ph.D | Baebies | Co-Founder, Chief Executive Officer & Board Member | 000 0000 |
| Vamsee Pamula Ph.D | Baebies | Co-Founder, President & Board Member | 000 0000 |
| William Hawkins III | Self | Board Member | 000 0000 |
Baebies Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Baebies Investors (36)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Aaron Biek | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| BOE Technology Group | Corporation | Minority | 000 0000 | 000000 0 | |
| Brett Rule | Angel (individual) | Minority | 000 0000 | 000000 0 | |
| Collective Capital Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| CureDuchenne Ventures | Corporate Venture Capital | Minority | 000 0000 | 000000 0 |